Login

BlackRock Favors Japan Stocks | Hiroyuki Shimizu, CEO, BlackRock Japan Co. Ltd 00:10:00

Share On Facebook Share On Twitter

Hiroyuki Shimizu is the CEO of BlackRock Japan Co. Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Alan Seabost on Small Business Resilience and M&A Opportunities
00:10:00
Opening up a world of opportunity|Noel Quinn,CEO, HSBC holdings USA Inc
00:10:00
Unlocking Success with Our Technical Advisory Services Team | Rajiv Sharma, Group CEO, Coats Group PLCCOA:LSE
00:10:00
Navigating Old Mutual's Leadership Transition: A Message from Chairperson Trevor Manuel | Trevor Manuel, Chairman, Old Mutual Limited.
00:10:00
Empress Royalty CEO Alexandra Woody-Sharon Discusses Strategic Growth and Investment Focus at One-to-One Conference
00:10:00
Advancing Risk-Informed Decision Making in Tailings Management
00:10:00
Welly Thomas Discusses the Growth Journey of PT Sumber Global Energy and Its Subsidiary's IPO Plans | Welly Thomas, CEO, PT Sumber Global Energy Tbk.
00:10:00
Economic Insights: Investment Webinar with PIMCO | Mission Wealth - Dan Ivascyn | Group Chief Investment Officer, PIMCO
00:10:00
Rising Demand and Scarce Supply: Warsaw's Apartment Market Faces Potential Price Surge | Jarosław Szanajca, CEO ,Dom Development SA.
00:00:00
Martin Brenner, DVM, Ph.D. CEO, Ibio Inc
00:10:00
Lazard Conférence-Débat avec André Comte-Sponville | Peter Orszag, CEO, Lazard Fr�res Gestion SASAS OF 29 SEP 2023
00:10:00
B2Gold Discusses Namibia Gold Project and Global Exploration Plans

© 2017 - Neuhu+